XML 89 R29.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL AND STOCK OPTIONS (Tables)

12 Months Ended

Jun. 30, 2013

Warrants and options [Member]

Stockholders Equity Note [Line Items]

A summary of all the warrants and options outstanding as of June 30, 2013 is presented in this table:

Warrants / Options	Exercise Price per Share		Options and Warrants for Common Stock		Options and Warrants Exercisable		Weighted Average Remaining Contractual Terms(in years)
Warrants:	$	1.00		1,977,245		1,977,245		0.41
	$	1.28		50,000		50,000		0.81
	$	1.40 - $ 1.50		1,606,226		1,606,226		1.28
	$	1.60		181,221		181,221		1.78
	$	1.80 - $ 1.91		2,455,003		2,455,003		0.92
	$	4.20		5,060,000		5,060,000		3.09
	$	5.00		3,220,000		3,220,000		4.22
Total warrants				14,549,695		14,549,695

Options:	$	0.00		99,500		96,500		6.37
	$	0.62		406,000		406,000		5.25
	$	1.04		37,500		37,500		5.16
	$	2.97		20,000		20,000		4.86
	$	3.50		900,000		900,000		3.56
	$	3.72 - $ 3.80		31,550		31,550		3.44
	$	4.00		42,500		42,500		3.30
	$	4.38 - $ 4.40		452,856		452,856		3.96
	$	6.80		36,250		36,250		4.37
	$	8.20		40,000		40,000		2.63
	$	20.00		142,500		142,500		2.98
Total options				2,208,656		2,205,656

Total warrants and options				16,758,351		16,755,351

Restricted Stock and Restricted Stock Units [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

Compensation expenses related to restricted stock and restricted stock units granted to employees and directors were recorded as follows:

	Year ended June 30,
	2013		2012		2011
Research and development expenses	$	711	$	1,163	$	1,027
General and administrative expenses		1,529		3,487		1,717
	$	2,240	$	4,650	$	2,744

Schedule of Unvested Restricted Stock Units

The following table summarizes the activities for unvested restricted stock units and restricted stock granted to employees and directors for the year ended June 30, 2013:

	Number
Unvested at the beginning of period		2,085,276
Granted		1,248,574
Forfeited		(90,213	)
Vested		(1,583,112	)
Unvested at the end of the period		1,660,525
Expected to vest after June 30, 2013		1,637,130

Consultant Restricted Stock Units And Restricted Stock [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

Compensation expenses related to restricted stock and restricted stock units granted to consultants were recorded as follows:

	Year ended June 30,
	2013		2012		2011
Research and development expenses	$	255	$	201	$	294
General and administrative expenses		278		20		178
	$	533	$	221	$	472

Schedule of Unvested Restricted Stock Units

The following table summarizes the activities for unvested restricted stock units and restricted stock granted to consultants for the year ended June 30, 2013:

	Number
Unvested at the beginning of period		66,000
Granted		123,206
Forfeited		(21,978	)
Vested		(167,228	)
Unvested at the end of the period		-

Employees and directors [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock Option Activity

A summary of the Company's share option activity for options granted to employees and directors under the Plans is as follows:

	Year ended June 30, 2013
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		2,082,172			3.87
Options exercised		(120,068	)		1.22
Options forfeited		(3,948	)		4.4
Options outstanding at end of the period		1,958,156			4.03		3.97		1,054
Options exercisable at the end of the period		1,958,156			4.03		3.97		1,054
Options vested		1,958,156			4.03		3.97		1,054

Schedule of Stock-based Compensation Expenses Recognized

Compensation expenses related to options granted to employees and directors were recorded as follows:

	Year ended June 30,
	2013		2012		2011
Research and development expenses	$	-	$	-	$	2
General and administrative expenses		-		-		2
	$	-	$	-	$	4

Consultants [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock Option Activity

A summary of the Company's activity related to options and warrants to consultants is as follows:

	Year ended June 30, 2013
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options and warrants outstanding at beginning of period		382,000			3.86
Options and warrants exercised		(66,500	)		1.13
Options and warrants outstanding at end of the period		315,500			4.44		4.03		425

Options and warrants exercisable at the end of the period		312,500			4.48		3.99		416

Options and warrants vested and expected to vest		315,500			4.44		4.03		425

Schedule of Stock-based Compensation Expenses Recognized

Compensation expenses related to options and warrants granted to consultants were recorded as follows:

	Year ended June 30,
	2013		2012		2011
Research and development expenses	$	-	$	19	$	32
General and administrative expenses		26		37		73
	$	26	$	56	$	105

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details